Global Angioplasty Balloons Market is Segmented By Product Type (Drug Eluting Balloons, Normal Balloons, Cutting/Scoring Balloons), By Application (Coronary Angioplasty, Peripheral Angioplasty), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Angioplasty Balloons Market Overview
The Global Angioplasty Balloons Market reached USD 2.2 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 2.9 billion by 2030. The global angioplasty balloons market market is expected to exhibit a CAGR of 3.5% during the forecast period (2023-2030).
Angioplasty balloons are vital medical devices used in a treatment known as percutaneous transluminal angioplasty (PTA) to treat a variety of cardiovascular ailments, most notably coronary artery disease. Angioplasty balloons can be used to treat acute cardiac problems such as heart attacks. The timely use of balloons in these cases can aid in reopening clogged arteries, restoring blood flow, and minimising heart muscle damage. The global angioplasty balloons market growth is driven by the increasing burden of cardiovascular diseases, the preference toward minimally invasive surgery and increasing geriatric populations.
Angioplasty Balloons Market Scope
|
Metrics |
Details |
|
CAGR |
3.5% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Product Type, Application, End User, and Region |
|
Regions Covered |
North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
|
Fastest Growing Region |
Asia-Pacific |
|
Largest Region |
North America |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product type Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Market key Insights. |
To Know More - Download Sample
Angioplasty Balloons Market Dynamics
Increasing Prevalence of Cardiovascular Diseases is Boosting the Global Angioplasty Balloons Market Growth
The global prevalence of cardiovascular diseases (CVD) is rising, posing a huge public health challenge. A variety of variables contribute to the rising prevalence of cardiovascular illnesses. Unhealthy diets, sedentary lives, tobacco use, obesity, high blood pressure, high cholesterol levels, diabetes, and ageing populations are some of these. For instance, according to WHO, cardiovascular diseases (CVDs) are the leading cause of death worldwide, claiming the lives of an estimated 18 million people each year.
CVDs are a collection of heart and blood vessel disorders that include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and others. Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of these deaths occur in adults under the age of 70. Unhealthy food, physical inactivity, cigarette use, and problematic alcohol consumption are the most major behavioural risk factors for heart disease and stroke. As a result, there is an increase in cardiovascular illnesses, which contributes to market growth.
High Costs and the Post-Operational Complications Associated with Angioplasty are Likely to Hamper the Market Growth
However, the angioplasty operation, including the angioplasty balloons, can be rather expensive. The angioplasty treatment, for instance, is usually performed in a hospital or a specialised cardiac centre, and the facility fees connected with the use of the operating room, equipment, and staff all add to the overall cost.
The services of the medical specialists engaged in the angioplasty operation, such as the interventional cardiologist, anesthesiologist, nurses, and technicians, are also extra. Their skill, effort, and resources all add to the procedure's final cost. And the hefty expense of the surgery will hinder market expansion.
Angioplasty Balloons Market Segmentation Analysis
The global angioplasty balloons market is segmented based product type, application, end user, and region.
The Drug-eluting Balloons Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period
The drug-eluting balloons segment accounted for the biggest market stake accounting for approximately 39.7% of the angioplasty balloons market in 2022. Drug-eluting balloons (DEBs) are being used to treat in-stent restenosis (ISR) instead of drug-eluting stents (DES). They are coated with a polymeric matrix that contains antiproliferative medicines that are released locally at the vessel wall as the balloon inflates.
Drug-eluting balloons (DEBs) are a type of balloon catheter that is utilised during coronary angioplasty treatments. These balloons are coated with medication, usually an anti-proliferative agent, which is delivered into the vessel wall as the balloon inflates. And the segment is being driven by FDA approvals and key companies' strategies.
For instance, on January 11, 2023, SELUTION SLR, MedAlliance's innovative sirolimus-eluting balloon, acquired conditional FDA IDE approval to begin its major clinical trial for the treatment of coronary de novo lesions. This comes less than eight months after the business earned its first IDE approval for SELUTION SLR in the treatment of below-the-knee (BTK) indications, as well as superficial femoral artery (SFA) occlusive disease, and coronary In-Stent Restenosis (ISR).
Source: DataM Intelligence Analysis (2023)
Angioplasty Balloons Market Geographical Shares
North America Holds a Dominant Position in the Global Angioplasty Balloons Market
North America is estimated to hold about 40.1% of the total market share throughout the forecast period. North America dominates the angioplasty balloons market and has the highest revenue share in the angioplasty balloons market. The presence of significant industry players, increased healthcare expenditure, and an increase in the number of percutaneous coronary interventions are the primary drivers of the regional market.
According to the Centers for Disease Control and Prevention (CDC), by 2022, about 7000,000 persons in the United States would die from heart disease each year, accounting for one out of every four deaths. As a result, there is a greater desire for improved treatment using innovative medical equipment, which is a primary factor driving the studied industry. All of these advancements are projected to strengthen the industry's robust product range and to provide attractive growth prospects to the market in this area.
Source: DataM Intelligence Analysis (2023)
Angioplasty Balloons Market Key Players
The major global players in the market include Boston Scientific Corporation, BIOTRONIK, Medtronic Plc, Cordis (Cardinal Health), Terumo Corporation, Abbott Laboratories, AngioDynamics, BD, INFINITY Angioplasty Balloon, and Koninklijke Philips N.V, among others.
Angioplasty Balloons Market Impact Analysis
Russia-Ukraine War Impact Analysis
The Russia-Ukraine is estimated to have a minimal impact on the global angioplasty balloons market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test product types, and devices is anticipated to have little influence over the global angioplasty balloons market in the forecast period.
Artificial Intelligence Impact Analysis
Artificial intelligence is anticipated to impact positively. AI algorithms can analyze medical imaging data, such as angiograms or intravascular ultrasound (IVUS) images, to identify and segment the blood vessels and lesions. This helps in the accurate measurement of vessel dimensions, identification of the target site for balloon dilation, and planning the procedure.
Key Developments
- On June 17, 2020, the FDA approved the INFINITY Angioplasty Balloon platform for PAD therapy. The US Food and Drug Administration (FDA) approved INFINITY Angioplasty Balloon's novel balloon platform INFINITY Angioplasty Balloon Catheter for the treatment of peripheral artery disease (PAD) by percutaneous transluminal angioplasty (PTA).
- In November 2020, Infinity Angioplasty Balloon Co. announced the commercial availability of its novel angioplasty balloon platform, the Infinity Angioplasty Balloon Catheter, as well as the completion of a First-in-Human clinical trial.
- On July 21, 2022, BrosMed Medical received 510(k) clearance from the US Food and Drug Administration for its Tiche 0.035" PTA Balloon Dilatation Catheter. Tiche is a 0.035-inch percutaneous transluminal angioplasty (PTA) catheter that is highly deliverable and can be used for a variety of peripheral angioplasty operations. BrosMed intends to commercialize the product in the United States first, with a CE accreditation expected soon after.
Why Purchase the Report?
- To visualize the global angioplasty balloons market segmentation based on product type, application, end-user, and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of angioplasty balloons market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key product types of all the major players.
The global angioplasty balloons market report would provide approximately 53 tables, 54 figures, and 195 Pages.
